Menu
Back to Journals » Cancer Management and Research » Volume 10
Original Research
PLNR≤20% may be a benefit from PORT for patients with IIIA-N2 NSCLC: a large population-based study
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 6,170 | Dovepress* | 5,010+ | 612 | 5,622 | |
| PubMed Central* | 1,160 | 116 | 1,276 | ||
| Totals | 6,170 | 728 | 6,898 | ||
| *Since 17 September 2018 | |||||
View citations on PubMed Central and Google Scholar